[1]
|
Taylor, P.N., Albrecht, D., Scholz, A., et al. (2018) Global Epidemiology of Hyperthyroidism and Hypothyroidism. Nature Reviews. Endocrinology, 14, 301-316. https://doi.org/10.1038/nrendo.2018.18
|
[2]
|
Roth, G.A., Abate, D., Abate, K.H., et al. (2018) Global, Regional, and National Age-Sex-Specific Mortality for 282 Causes of Death in 195 Countries and Territories, 1980-2017: A Systematic Analysis for the Global Burden of Disease Study 2017. The Lancet, 392, 1736-1788. https://doi.org/10.1016/S0140-6736(18)32203-7
|
[3]
|
Engholm, G., Ferlay, J., Christensen, N., Bray, F., et al. (2010) NORDCAN—A Nordic Tool for Cancer Information, Planning, Quality Control and Research. Acta Oncologica, 49, 725-736. https://doi.org/10.3109/02841861003782017
|
[4]
|
Beatson, G.T. (1896) On the Treatment of Inoperable Cases of Carcinoma of the Mamma: Suggestions for a New Method of Treatment, with Illustrative Cases. Transactions. Medico-Chirurgical Society of Edinburgh, 15, 153-179.
|
[5]
|
Krashin, E., Piekiełko-Witkowska, A., Ellis, M. and Ashur-Fabian, O. (2019) Thyroid Hormones and Cancer: A Comprehensive Review of Preclinical and Clinical Studies. Frontiers in Endocrinology, 10, Article 59. https://doi.org/10.3389/fendo.2019.00059
|
[6]
|
Davis, F.B., Mousa, S.A., O’Connor, L., Mohamed, S., et al. (2004) Proangiogenic Action of Thyroid Hormone Is Fibroblast Growth Factor-Dependent and Is Initiated at the Cell Surface. Circulation Research, 94, 1500-1506. https://doi.org/10.1161/01.RES.0000130784.90237.4a
|
[7]
|
Bergh, J.J., Lin, H., Lansing, L., Mohamed, S.N., et al. (2005) Integrin αVβ3 Contains a Cell Surface Receptor Site for Thyroid Hormone That Is Linked to Activation of Mitogen-Activated Protein Kinase and Induction of Angiogenesis. Endocrinology, 146, 2864-2871. https://doi.org/10.1210/en.2005-0102
|
[8]
|
Lin, H.Y., Davis, F.B., Gordinier, J.K., et al. (1999) Thyroid Hormone Induces Activation of Mitogen-Activated Protein Kinase in Cultured Cells. American Journal of Physiology, 276, C1014-C1024. https://doi.org/10.1152/ajpcell.1999.276.5.C1014
|
[9]
|
Lin, H., Su, Y., Hsieh, M., Lin, S., et al. (2013) Nuclear Monomeric Integrin αv in Cancer Cells Is a Coactivator Regulated by Thyroid Hormone. The FASEB Journal, 27, 3209-3216. https://doi.org/10.1096/fj.12-227132
|
[10]
|
Yeh, N., Chou, C., Weng, S., Yang, C., et al. (2013) Hyperthyroidism and Thyroid Cancer Risk: A Population-Based Cohort Study. Experimental and Clinical Endocrinology & Diabetes, 121, 402-406. https://doi.org/10.1055/s-0033-1341474
|
[11]
|
Hellevik, A.I., Asvold, B.O., Bjøro, T., Romundstad, P.R., et al. (2009) Thyroid Function and Cancer Risk: A Prospective Population Study. Cancer Epidemiology, Biomarkers & Prevention, 18, 570-574. https://doi.org/10.1158/1055-9965.EPI-08-0911
|
[12]
|
Hercbergs, A.H., Ashur-Fabian, O. and Garfield, D. (2010) Thyroid Hormones and Cancer: Clinical Studies of Hypothyroidism in Oncology. Current Opinion in Endocrinology, Diabetes, and Obesity, 17, 432-436. https://doi.org/10.1097/MED.0b013e32833d9710
|
[13]
|
Cristofanilli, M., Yamamura, Y., Kau, S., Bevers, T., et al. (2005) Thyroid Hormone and Breast Carcinoma. Primary Hypothyroidism Is Associated with a Reduced Incidence of Primary Breast Carcinoma. Cancer, 103, 1122-1128. https://doi.org/10.1002/cncr.20881
|
[14]
|
Backwinkel, K. and Jackson, A.S. (1964) Some Features of Breast Cancer and Thyroid Deficiency. Report of 280 Cases. Cancer, 17, 1174-1176. https://doi.org/10.1002/1097-0142(196409)17:9<1174::AID-CNCR2820170913>3.0.CO;2-C
|
[15]
|
Hercbergs, A., Mason, J., Reddy, C. and Elson, P. (2004) Thyroid Hormones and Lung Cancer: Primary Hypothyroidism Is Prognostically Significant for Survival in Lung Cancer. Cancer Research, 64, Article 1024.
|
[16]
|
Moeller, L.C. and Führer, D. (2013) Thyroid Hormone, Thyroid Hormone Receptors, and Cancer: A Clinical Perspective. Endocrine-Related Cancer, 20, R19-R29. https://doi.org/10.1530/ERC-12-0219
|
[17]
|
Cheng, S., Leonard, J.L. and Davis, P.J. (2010) Molecular Aspects of Thyroid Hormone Actions. Endocrine Reviews, 31, 139-170. https://doi.org/10.1210/er.2009-0007
|
[18]
|
Yalcin, M., Dyskin, E., Lansing, L., Bharali, D.J., et al. (2010) Tetraiodothyroacetic Acid (Tetrac) and Nanoparticulate Tetrac Arrest Growth of Medullary Carcinoma of the Thyroid. The Journal of Clinical Endocrinology and Metabolism, 95, 1972-1980. https://doi.org/10.1210/jc.2009-1926
|
[19]
|
De Berardinis, R.J. and Chandel, N.S. (2020) We Need to Talk About the Warburg Effect. Nature Metabolism, 2, 127-129. https://doi.org/10.1038/s42255-020-0172-2
|
[20]
|
Ghergurovich, J.M., Lang, J.D., Levin, M.K., Briones, N., et al. (2021) Local Production of Lactate, Ribose Phosphate, and Amino Acids by Human Triple-Negative Breast Cancer. Med, 2, 736-754.E6. https://doi.org/10.1016/j.medj.2021.03.009
|
[21]
|
Martínez-Reyes, I. and Chandel, N.S. (2021) Cancer Metabolism: Looking Forward. Nature Reviews. Cancer, 21, 669-680. https://doi.org/10.1038/s41568-021-00378-6
|
[22]
|
Surks, M.I., Ortiz, E., Daniels, G.H., Sawin, C.T., et al. (2004) Subclinical Thyroid Disease: Scientific Review and Guidelines for Diagnosis and Management. JAMA, 291, 228-238. https://doi.org/10.1001/jama.291.2.228
|
[23]
|
Hartmann, K. (2015) Thyroid Disorders in the Oncology Patient. Journal of the Advanced Practitioner in Oncology, 6, 99-106. https://doi.org/10.6004/jadpro.2015.6.2.2
|